HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.

Abstract
This study documents the reactions of the monoclonal antibody KP-1, which detects histiocytes in paraffin sections, with 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. The soft tissue sarcomas had been previously immunophenotyped. Positive staining was obtained in all categories of sarcoma except clear-cell sarcomas. Most categories of sarcoma showed staining in less than 10% of tumour cells although a minority of leiomyosarcomas showed more extensive staining. Five of 7 malignant melanomas were also positive while all lymphomas and carcinomas were negative. We conclude that KP-1 positivity is not helpful in supporting the histiocytic origin of a tumour and is of limited value in the differential diagnosis of soft tissue sarcomas or their separation from other categories of malignancy.
AuthorsM Cassidy, B Loftus, A Whelan, B Sabt, D Hickey, K Henry, M Leader
JournalVirchows Archiv : an international journal of pathology (Virchows Arch) Vol. 424 Issue 6 Pg. 635-40 ( 1994) ISSN: 0945-6317 [Print] Germany
PMID7519954 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers, Tumor
  • CD68 antigen, human
Topics
  • Antigens, CD (analysis)
  • Antigens, Differentiation, Myelomonocytic (analysis)
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (chemistry)
  • Carcinoma (chemistry)
  • Female
  • Humans
  • Lymphoma (chemistry)
  • Melanoma (chemistry)
  • Phyllodes Tumor (chemistry)
  • Sarcoma (chemistry)
  • Soft Tissue Neoplasms (chemistry)
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: